Nicholas Tschernia

Statistics

Publications

Citations

H-Index

Active since

2020

Affiliations

University of North Carolina at Chapel Hill(Current)

National Institutes of Health

Nicholas Tschernia is an author at University of North Carolina at Chapel Hill specializing in oncology, cancer immunotherapy, and immunotherapy safety.

ORCID

Publications per year

2020–2023

Publications

Safety and Efficacy of Pembrolizumab Prior to Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia

Nicholas Tschernia, Vaibhav Kumar, Dominic T. Moore et al. · Transplantation and Cellular Therapy · 2021 · 20 citations · Full text

Life Sciences, Immunology, Oncology +17

Non-Relapse Mortality in <i>TP53</i>-Mutated MDS/AML - a Multi-Center Collaborative Study

Michael Byrne, Tony Kurian, Dilan A. Patel et al. · Blood · 2021 · 16 citations

Medicine, Oncology, Molecular Oncology +10

A Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors

Margaret E. Gatti‐Mays, Nicholas Tschernia, Julius Strauss et al. · The Oncologist · 2023 · 16 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume I—conceptual challenges

Sergio Rutella, Michael A. Cannarile, Sacha Gnjatic et al. · Journal for ImmunoTherapy of Cancer · 2020 · 13 citations · Full text

Medicine, Biomedical Informatics, Oncology +17

Patient-reported outcomes in CD30-directed CAR-T cells against relapsed/refractory CD30+ lymphomas

Nicholas Tschernia, Hillary Heiling, Allison M. Deal et al. · Journal for ImmunoTherapy of Cancer · 2023 · 13 citations · Full text

Medicine, Immunology, Oncology +17

1–5 of 5